The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
Open accessAbstract
Low high-density lipoprotein cholesterol (HDL-C) characterizes an atherogenic dyslipidemia that reflects adverse lifestyle choices, impaired metabolism, and increased cardiovascular risk. Low HDL-C is also associated with increased risk of inflammatory disorders, malignancy, diabetes, and other diseases. This epidemiologic evidence has not translated to raising HDL-C as a viable therapeutic target, partly because HDL-C does not reflect high-density lipoprotein (HDL) function. Mendelian randomization analyses that have found no evidence of a causal relationship between HDL-C levels and cardiovascular risk have decreased interest in increasing HDL-C levels as a therapeutic target. HDLs comprise distinct subpopulations of particles of varying size, charge, and composition that have several dynamic and context-dependent functions, especially with respect to acute and chronic inflammatory states. These functions include reverse cholesterol transport, inhibition of inflammation and oxidation, and antidiabetic properties. HDLs can be anti-inflammatory (which may protect against atherosclerosis and diabetes) and proinflammatory (which may help clear pathogens in sepsis). The molecular regulation of HDLs is complex, as evidenced by their association with multiple proteins, as well as bioactive lipids and noncoding RNAs. Clinical investigations of HDL biomarkers (HDL-C, HDL particle number, and apolipoprotein A through I) have revealed nonlinear relationships with cardiovascular outcomes, differential relationships by sex and ethnicity, and differential patterns with coronary versus noncoronary events. Novel HDL markers may also have relevance for heart failure, cancer, and diabetes. HDL function markers (namely, cholesterol efflux capacity) are associated with coronary disease, but they remain research tools. Therapeutics that manipulate aspects of HDL metabolism remain the holy grail. None has proven to be successful, but most have targeted HDL-C, not metrics of HDL function. Future therapeutic strategies should focus on optimizing HDL function in the right patients at the optimal time in their disease course. We provide a framework to help the research and clinical communities, as well as funding agencies and stakeholders, obtain insights into current thinking on these topics, and what we predict will be an exciting future for research and development on HDLs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Evacetrapib and cardiovascular outcomes in high-risk vascular disease
Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., Barter, P. J., Brewer, H. B., Fox, K. A. A., Gibson, C. M., Granger, C., Menon, V., Montalescot, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609581 · Cited by 801
Ference, B. A., Kastelein, J. J. P., Ray, K. K., Ginsberg, H. N., Chapman, M. J., Packard, C. J., Laufs, U., Oliver-Williams, C., Wood, A. M., Butterworth, A. S., et al. (2019) · JAMA · doi:10.1001/jama.2018.20045 · Cited by 703
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Cartier, A., & Hla, T. (2019) · Science · doi:10.1126/science.aar5551 · Cited by 613
Zanoni, P., Khetarpal, S. A., Larach, D. B., Hancock-Cerutti, W. F., Millar, J. S., Cuchel, M., DerOhannessian, S., Kontush, A., Surendran, P., Saleheen, D., et al. (2016) · Science · doi:10.1126/science.aad3517 · Cited by 545
Lipid-Related Markers and Cardiovascular Disease Prediction
(2012) · JAMA · doi:10.1001/jama.2012.6571 · Cited by 539
High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168690 · Cited by 508
Self-citationDe Nardo, D., Labzin, L. I., Kono, H., Seki, R., Schmidt, S. V., Beyer, M., Xu, D., Zimmer, S., Lahrmann, C., Schildberg, F. A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2784 · Cited by 462
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice
Tward, A., Xia, Y.-R., Wang, X.-P., Shi, Y.-S., Park, C., Castellani, L. W., Lusis, A. J., & Shih, D. M. (2002) · Circulation · doi:10.1161/01.cir.0000023623.87083.4f · Cited by 455
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Kontush, A., Chantepie, S., & Chapman, M. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000091338.93223.e8 · Cited by 452
Yvan-Charvet, L., Welch, C., Pagler, T. A., Ranalletta, M., Lamkanfi, M., Han, S., Ishibashi, M., Li, R., Wang, N., & Tall, A. R. (2008) · Circulation · doi:10.1161/circulationaha.108.793869 · Cited by 439
Riwanto, M., Rohrer, L., Roschitzki, B., Besler, C., Mocharla, P., Mueller, M., Perisa, D., Heinrich, K., Altwegg, L., von Eckardstein, A., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.108753 · Cited by 337
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis
Westerterp, M., Fotakis, P., Ouimet, M., Bochem, A. E., Zhang, H., Molusky, M. M., Wang, W., Abramowicz, S., la Bastide-van Gemert, S., Wang, N., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032636 · Cited by 331
Self-citationCharacterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs
Wagner, J., Riwanto, M., Besler, C., Knau, A., Fichtlscherer, S., Röxe, T., Zeiher, A. M., Landmesser, U., & Dimmeler, S. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300741 · Cited by 325
Ference, B. A., Kastelein, J. J. P., Ginsberg, H. N., Chapman, M. J., Nicholls, S. J., Ray, K. K., Packard, C. J., Laufs, U., Brook, R. D., Oliver-Williams, C., et al. (2017) · JAMA · doi:10.1001/jama.2017.11467 · Cited by 304
MicroRNA-223 coordinates cholesterol homeostasis
Vickers, K. C., Landstreet, S. R., Levin, M. G., Shoucri, B. M., Toth, C. L., Taylor, R. C., Palmisano, B. T., Tabet, F., Cui, H. L., Rye, K.-A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215767111 · Cited by 253
Self-citationYvan-Charvet, L., Kling, J., Pagler, T., Li, H., Hubbard, B., Fisher, T., Sparrow, C. P., Taggart, A. K., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207142 · Cited by 240
Hernáez, Á., Castañer, O., Elosua, R., Pintó, X., Estruch, R., Salas-Salvadó, J., Corella, D., Arós, F., Serra-Majem, L., Fiol, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.023712 · Cited by 229
Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
Georgila, K., Vyrla, D., & Drakos, E. (2019) · Cancers · doi:10.3390/cancers11081097 · Cited by 224
Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity
Westerterp, M., Gautier, E. L., Ganda, A., Molusky, M. M., Wang, W., Fotakis, P., Wang, N., Randolph, G. J., D'Agati, V. D., Yvan-Charvet, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.005 · Cited by 218
Self-citationStructure of apolipoprotein A-I in spherical high density lipoproteins of different sizes
Silva, R. A. G. D., Huang, R., Morris, J., Fang, J., Gracheva, E. O., Ren, G., Kontush, A., Jerome, W. G., Rye, K.-A., & Davidson, W. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803626105 · Cited by 206
Self-citationYvan-Charvet, L., Matsuura, F., Wang, N., Bamberger, M. J., Nguyen, T., Rinninger, F., Jiang, X.-C., Shear, C. L., & Tall, A. R. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.106.138347 · Cited by 201
Mora, S., Otvos, J. D., Rosenson, R. S., Pradhan, A., Buring, J. E., & Ridker, P. M. (2010) · Diabetes · doi:10.2337/db09-1114 · Cited by 198
Nicholls, S. J., Andrews, J., Kastelein, J. J. P., Merkely, B., Nissen, S. E., Ray, K. K., Schwartz, G. G., Worthley, S. G., Keyserling, C., Dasseux, J.-L., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2121 · Cited by 185
Ray, K. K., Nicholls, S. J., Buhr, K. A., Ginsberg, H. N., Johansson, J. O., Kalantar-Zadeh, K., Kulikowski, E., Toth, P. P., Wong, N., Sweeney, M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3308 · Cited by 166
Ruiz, M., Frej, C., Holmér, A., Guo, L. J., Tran, S., & Dahlbäck, B. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308435 · Cited by 162
Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence
Chew, W. S., Torta, F. T., Ji, S., Choi, H., Begum, H., Sim, X., Khoo, C. M., Khoo, E. Y. H., Ong, W., van Dam, R. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126925 · Cited by 161
Abderrahmani, A., Niederhäuser, G., Favre, D., Abdelli, S., Ferdaoussi, M., Yang, J. Y., Regazzi, R., Widmann, C., & Waeber, G. (2007) · Diabetologia · doi:10.1007/s00125-007-0642-z · Cited by 159
Fotakis, P., Kothari, V. M., Thomas, D. G., Westerterp, M., Molusky, M. M., Altin, E. S., Abramowicz, S., Wang, N., He, Y., Heinecke, J. W., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313253 · Cited by 158
Self-citationHDL in sepsis – risk factor and therapeutic approach
Morin, E. E., Guo, L., Schwendeman, A. A., & Li, X. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00244 · Cited by 154
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk
Zewinger, S., Drechsler, C., Kleber, M. E., Dressel, A., Riffel, J., Triem, S., Lehmann, M., Kopecky, C., Säemann, M. D., Lepper, P. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv352 · Cited by 153
Hirata, A., Sugiyama, D., Watanabe, M., Tamakoshi, A., Iso, H., Kotani, K., Kiyama, M., Yamada, M., Ishikawa, S., Murakami, Y., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.014 · Cited by 150
Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R. E., Vaisar, T., de Beer, M. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.961193 · Cited by 145
Thacker, S. G., Zarzour, A., Chen, Y., Alçiçek, M. S., Freeman, L. A., Sviridov, D. O., Demosky, S. J., & Remaley, A. T. (2016) · Immunology · doi:10.1111/imm.12638 · Cited by 145
Self-citationLipoprotein carriers of microRNAs
Michell, D. L., & Vickers, K. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.011 · Cited by 141
van der Vorst, E. P. C., Theodorou, K., Wu, Y., Hoeksema, M. A., Goossens, P., Bursill, C. A., Aliyev, T., Huitema, L. F. A., Tas, S. W., Wolfs, I. M. J., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.013 · Cited by 141
Self-citationZhou, P., Li, B., Liu, B., Chen, T., & Xiao, J. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.039 · Cited by 139
Mauldin, J., Nagelin, M. H., Wojcik, A. J., Srinivasan, S. R., Skaflen, M. D., Ayers, C. R., McNamara, C. A., & Hedrick, C. C. (2008) · Circulation · doi:10.1161/circulationaha.107.741314 · Cited by 137
HDL Remodeling During the Acute Phase Response
Jahangiri, A., de Beer, M. C., Noffsinger, V. P., Tannock, L. R., Ramaiah, C., Webb, N. R., van der Westhuyzen, D. R., & de Beer, F. C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178681 · Cited by 135
Ståhlman, M., Fagerberg, B., Adiels, M., Ekroos, K., Chapman, J., Kontush, A., & Borén, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.009 · Cited by 125
The Changing Face of HDL and the Best Way to Measure It
Karathanasis, S. K., Freeman, L. A., Gordon, S. M., & Remaley, A. T. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257725 · Cited by 122
Self-citationStructure-function relationships of HDL in diabetes and coronary heart disease
Cardner, M., Yalçınkaya, M., Götze, S., Luca, E., Baláž, M., Hunjadi, M., Hartung, J., Shemet, A., Kränkel, N., Radosavljevic, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131491 · Cited by 121
Wulff, A. B., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310473 · Cited by 117
Jensen, M. K., Aroner, S. A., Mukamal, K. J., Furtado, J. D., Post, W. S., Tsai, M. Y., Tjønneland, A. M., Polak, J. F., Rimm, E. B., Overvad, K., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031276 · Cited by 114
Shea, S., Stein, J. H., Jorgensen, N. W., McClelland, R. L., Tascau, L., Shrager, S., Heinecke, J. W., Yvan‐Charvet, L., & Tall, A. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311366 · Cited by 114
Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies
Furtado, J. D., Yamamoto, R., Melchior, J., Andraski, A. B., Gamez-Guerrero, M., Mulcahy, P., He, Z., Cai, T., Davidson, W. S., & Sacks, F. M. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311607 · Cited by 103
Shamburek, R. D., Bakker-Arkema, R. G., Auerbach, B. J., Krause, B. R., Homan, R., Amar, M. J., Freeman, L. A., & Remaley, A. T. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.12.007 · Cited by 94
Self-citationIntracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment
Kini, A. S., Vengrenyuk, Y., Shameer, K., Maehara, A., Meerarani, P., Yoshimura, T., Matsumura, M., Aquino, M. B., Haider, N., Johnson, K. W., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.029 · Cited by 93
Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314050 · Cited by 91
Wu, B. J., Chen, K., Shrestha, S., Ong, K. L., Barter, P. J., & Rye, K. (2012) · Circulation Research · doi:10.1161/circresaha.111.300104 · Cited by 86
Self-citationMutharasan, R. K., Thaxton, C. S., Berry, J. D., Daviglus, M. L., Yuan, C., Sun, J., Ayers, C. R., Lloyd‐Jones, D. M., & Wilkins, J. T. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p069039 · Cited by 86
Lipoprotein X Causes Renal Disease in LCAT Deficiency
Ossoli, A., Neufeld, E. B., Thacker, S. G., Vaisman, B. L., Pryor, M., Freeman, L. A., Brantner, C. A., Baranova, I. N., Francone, N. O., Demosky, S. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150083 · Cited by 85
Self-citationDragoljevic, D., Kraakman, M. J., Nagareddy, P. R., Ngo, D., Shihata, W., Kammoun, H. L., Whillas, A., Lee, M. K. S., Al‐Sharea, A., Pernes, G., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy119 · Cited by 85
Singh, K., Chandra, A., Sperry, T., Joshi, P. H., Khera, A., Virani, S. S., Ballantyne, C. M., Otvos, J. D., Dullaart, R. P. F., Gruppen, E. G., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045713 · Cited by 83
Self-citationSmoak, K. A., Aloor, J. J., Madenspacher, J. H., Merrick, B. A., Collins, J. B., Zhu, X., Cavigiolio, G., Oda, M. N., Parks, J. S., & Fessler, M. B. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.006 · Cited by 81
Shamburek, R. D., Bakker-Arkema, R. G., Shamburek, A. M., Freeman, L. A., Amar, M. J., Auerbach, B. J., Krause, B. R., Homan, R., Adelman, S. J., Collins, H. L., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306223 · Cited by 81
Self-citationLone, M. A., Hülsmeier, A. J., Saied, E. M., Karsai, G., Arenz, C., von Eckardstein, A., & Hornemann, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002391117 · Cited by 81
Bioinformatic analysis of endogenous and exogenous small RNAs on lipoproteins
Allen, R. M., Zhao, S., Solano, M. A. R., Zhu, W., Michell, D. L., Wang, Y., Shyr, Y., Sethupathy, P., Linton, M. F., Graf, G. A., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1506198 · Cited by 80
Karjalainen, M. K., Holmes, M. V., Wang, Q., Anufrieva, O., Kähönen, M. A. P., Lehtimäki, T. J., Havulinna, A. S., Kristiansson, K., Salomaa, V. V., Perola, M., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.002 · Cited by 79
Salahuddin, T., Natarajan, B., Playford, M. P., Joshi, A. A., Teague, H., Masmoudi, Y., Selwaness, M., Chen, M. Y., Bluemke, D. A., & Mehta, N. N. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv339 · Cited by 77
Reconstituted HDL for the acute treatment of acute coronary syndrome
Krause, B. R., & Remaley, A. T. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000020 · Cited by 75
Self-citationOldoni, F., Baldassarre, D., Castelnuovo, S., Ossoli, A., Amato, M., van Capelleveen, J. C., Hovingh, G. K., de Groot, E., Bochem, A. E., Simonelli, S., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034706 · Cited by 75
Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate
Kurano, M., Tsukamoto, K., Shimizu, T., Kassai, H., Nakao, K., Aiba, A., Hara, M., & Yatomi, Y. (2020) · Diabetes · doi:10.2337/db19-0811 · Cited by 74
Melchior, J., Street, S. E., Andraski, A. B., Furtado, J. D., Sacks, F. M., Shute, R. L., Greve, E. I., Swertfeger, D. K., Li, H., SHAH, A. S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075382 · Cited by 72
Khan, A. A., Mundra, P. A., Straznicky, N. E., Nestel, P. J., Wong, G., Tan, R., Huynh, K., Ng, T. W., Mellett, N. A., Weir, J. M., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310212 · Cited by 70
Gille, A., D’Andrea, D. M., Tortorici, M. A., Härtel, G., & Wright, S. D. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310538 · Cited by 70
Meikle, P. J., Formosa, M. F., Mellett, N. A., Jayawardana, K. S., Giles, C., Bertovic, D. A., Jennings, G., Childs, W., Reddy, M., Carey, A. L., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011792 · Cited by 66
Kopecky, C., Genser, B., Drechsler, C., Krane, V., Kaltenecker, C. C., Hengstschläger, M., März, W., Wanner, C., Säemann, M. D., & Weichhart, T. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06560714 · Cited by 64
Wu, Z., Gogonea, V., Lee, X., May, R., Pipich, V., Wagner, M. A., Undurti, A., Tallant, T. C., Baleanu‐Gogonea, C., Charlton, F., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209130 · Cited by 63
Self-citationTherapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk
Masson, W. M., Lobo, M., Siniawski, D. A., Huerin, M. S., Molinero, G., Valéro, R., & Nogueira, J. P. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.02.005 · Cited by 62
Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins
Bochem, A. E., van der Valk, F. M., Tolani, S., Stroes, E. S. G., Westerterp, M., & Tall, A. R. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304959 · Cited by 56
Self-citationBeta cell secretion of miR-375 to HDL is inversely associated with insulin secretion
Sedgeman, L. R., Beysen, C., Solano, M. A. R., Michell, D. L., Sheng, Q., Zhao, S., Turner, S., Linton, M. F., & Vickers, K. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-40338-7 · Cited by 56
Role of High‐Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control
Manandhar, B., Cochran, B. J., & Rye, K. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013531 · Cited by 56
Self-citationEvaluation of MicroRNA375 as a Novel Biomarker for Graft Damage in Clinical Islet Transplantation
Kanak, M. A., Takita, M., Shahbazov, R., Lawrence, M. C., Chung, W. Y., Dennison, A. R., Levy, M. F., & Naziruddin, B. (2015) · Transplantation · doi:10.1097/tp.0000000000000625 · Cited by 55
Shao, B., & Heinecke, J. W. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1402680 · Cited by 55
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
Estrada-Luna, D., Ortiz-Rodríguez, M. A., Medina-Briseño, L., Carreón‐Torres, E., Vega, J. A. I., Sharma, A. K., Cancino‐Díaz, J. C., Pérez-Méndez, O. A., Belefant‐Miller, H., & Cabrera, G. B. (2018) · Molecules · doi:10.3390/molecules23112730 · Cited by 54
Xu, G., Lou, N., Shi, H., Xu, Y., Ruan, H., Xiao, W., Liu, L., Li, X., Xiao, H., Qiu, B., et al. (2018) · BMC Cancer · doi:10.1186/s12885-017-3761-z · Cited by 52
Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer
Shi, F., Wu, H., Qu, K., Sun, Q., Li, F., Shi, C., Li, Y., Xiong, X., Qin, Q., Yu, T., et al. (2018) · Clinical Proteomics · doi:10.1186/s12014-018-9194-0 · Cited by 52
Asztalos, B. F., Horvath, K. V., & Schaefer, E. J. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311117 · Cited by 50
Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity
Zvintzou, E., Lhomme, M., Chasapi, S., Filou, S., Theodoropoulos, V., Xapapadaki, E., Kontush, A., Spyroulias, G. A., Tellis, C. C., Tselepis, A. D., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m077925 · Cited by 49
Silbernagel, G., Scharnagl, H., Kleber, M. E., Delgado, G., Stojaković, T., Laaksonen, R., Erdmann, J., Rankinen, T., Bouchard, C., Landmesser, U., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.024 · Cited by 49
Siebel, A. L., Trinh, S. K., Formosa, M. F., Mundra, P. A., Natoli, A. K., Reddy-Luthmoodoo, M., Huynh, K., Khan, A. A., Carey, A. L., van Hall, G., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.03.002 · Cited by 46
Self-citationYalçınkaya, M., Kerksiek, A., Gebert, K., Annema, W., Sibler, R., Radosavljevic, S., Lütjohann, D., Rohrer, L., & von Eckardstein, A. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000509 · Cited by 46
Tabet, F., Torres, L., Ong, K. L., Shrestha, S., Choteau, S. A., Barter, P. J., Clifton, P. M., & Rye, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151061 · Cited by 45
Self-citationAssociation of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death
Natarajan, P., Collier, T., Jin, Z., Lyass, A., Li, Y., Ibrahim, N. E., Mukai, R., McCarthy, C. P., Massaro, J. M., D’Agostino, R. B., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.073 · Cited by 45
Amin, R., Muthuramu, I., Aboumsallem, J. P., Mishra, M., Jacobs, F., & Geest, B. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18092012 · Cited by 43
Simionescu, N., Niculescu, L. S., Carnuta, M. G., Sanda, G. M., Stancu, C. S., Popescu, A. C., Popescu, M. R., Vlad, A., Dimulescu, D. R., Simionescu, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161201 · Cited by 42
Freeman, L. A., Demosky, S. J., Konaklieva, M. I., Kuskovsky, R., Aponte, A. M., Ossoli, A., Gordon, S. M., Koby, R. F., Manthei, K. A., Shen, M., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240457 · Cited by 41
Self-citationPlasma lipid transfer proteins: The role of PLTP and CETP in atherogenesis
Chowaniec, Z., & Skoczyńska, A. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/67968 · Cited by 41
Emmens, J. E., Jones, D. J. L., Cao, T. H., Chan, D. C. S., Romaine, S. P. R., Quinn, P. A., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1101 · Cited by 40
Khalil, A., Fülöp, T., & Berrougui, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7998 · Cited by 40
Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate
Sutter, I., Park, R., Othman, A., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050021 · Cited by 39
Orsoni, A., Thérond, P., Tan, R., Giral, P., Robillard, P., Kontush, A., Meikle, P. J., & Chapman, M. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p068585 · Cited by 37
Reconstituted High-Density Lipoprotein Shortens Cardiac Repolarization
den Ruijter, H. M., Franssen, R., Verkerk, A. O., van Wijk, D. F., Vaessen, S. F. C., Holleboom, A. G., Levels, J. H. M., Opthof, T., Sungnoon, R., Stroes, E. S. G., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.072 · Cited by 36
An evaluation of RVX-208 for the treatment of atherosclerosis
Nikolić, D., Rizzo, M., Mikhailidis, D. P., Wong, N. C. W., & Banach, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1083010 · Cited by 36
Impact of ADCY9 Genotype on Response to Anacetrapib
Hopewell, J. C., Ibrahim, M. A.-H., Hill, M., Shaw, P. M., Braunwald, E., Blaustein, R. O., Bowman, L. J., Landray, M., Sabatine, M. S., Collins, R., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.041546 · Cited by 36
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
Schwartz, G. G., Leiter, L. A., Ballantyne, C. M., Barter, P. J., Black, D. M., Kallend, D. G., Laghrissi‐Thode, F., Leitersdorf, E., McMurray, J. J. V., Nicholls, S. J., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2204 · Cited by 36
Wang, Y., Wang, Z., Wang, F.-H., Lei, X., Yan, S., Wang, D., Zhang, F., Xu, R., Wang, L.-Y., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10145 · Cited by 35
Ganda, A., Yvan‐Charvet, L., Zhang, Y., Lai, E. J., Regunathan-Shenk, R., Hussain, F. N., Avasare, R. S., Chakraborty, B., Febus, A. J., Vernocchi, L., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.05.001 · Cited by 34
Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation
Ćurčić, S., Holzer, M., Pasterk, L., Knuplez, E., Eichmann, T. O., Frank, S., Zimmermann, R., Schicho, R., Heinemann, Á., & Marsche, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-08136-1 · Cited by 34
High-density lipoprotein mimetics: promises and challenges
Sviridov, D., & Remaley, A. T. (2015) · Biochemical Journal · doi:10.1042/bj20150832 · Cited by 33
Self-citationA novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans
Cuchel, M., Raper, A. C., Conlon, D., Pryma, D. A., Freifelder, R. H., Poria, R., Cromley, D. A., Li, X., Dunbar, R. L., French, B. C., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075226 · Cited by 33
Anastasius, M. O., Luquain‐Costaz, C., Kockx, M., Jessup, W., & Kritharides, L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.002 · Cited by 30
Reproducible Determination of High-Density Lipoprotein Proteotypes
Goetze, S., Frey, K., Rohrer, L., Radosavljevic, S., Krützfeldt, J., Landmesser, U., Bueter, M., Pedrioli, P. G. A., von Eckardstein, A., & Wollscheid, B. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00429 · Cited by 29
Aroner, S. A., Furtado, J. D., Sacks, F. M., Tsai, M. Y., Mukamal, K. J., McClelland, R. L., & Jensen, M. K. (2019) · Diabetologia · doi:10.1007/s00125-019-4847-8 · Cited by 27
Torres, L., Zhu, W., Öhrling, G., Larsson, R., Patel, M., Wiese, C. B., Rye, K., Vickers, K. C., & Tabet, F. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.227 · Cited by 27
Self-citationInborn errors of apolipoprotein A-I metabolism: implications for disease, research and development
Zanoni, P., & von Eckardstein, A. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000667 · Cited by 26
Zimetti, F., de Freitas, W. M., Campos‐Staffico, A. M., Daher, M., Adorni, M. P., Bernini, F., Sposito, A. C., & Zanotti, I. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p079525 · Cited by 23
The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease
Valanti, E.-K., Chroni, A., & Sanoudou, D. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000615 · Cited by 20
Rapid Affinity Enrichment of Human Apolipoprotein A-I Associated Lipoproteins for Proteome Analysis
Collier, T. S., Jin, Z., Topbas, C., & Bystrom, C. E. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00816 · Cited by 18
Role of niacin in current clinical practice.
Sharma, A., & Madan, N. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05826-3 · Cited by 12
Zhou, J., Zhang, Q., Wang, Y., Gao, P., & Chen, D. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2018.1401421 · Cited by 11
Sensitive and reproducible determination of clinical HDL proteotypesPreprint
Goetze, S., Frey, K., Rohrer, L., Radosavljevic, S., Krützfeldt, J., Landmesser, U., Bueter, M., Pedrioli, P. G. A., von Eckardstein, A., & Wollscheid, B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.191312 · Cited by 3
Cited by
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein, A., Nordestgaard, B. G., Remaley, A. T., & Catapano, A. L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac605 · Cited by 401
Self-citationBorràs, C., Mercer, A., Sirisi, S., Alcolea, D., Escolà-Gil, J. C., Blanco-Vaca, F., & Tondo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169356 · Cited by 39
Araújo, B., Arrighini, G. S., Queiroga, F., Mansouri, E. S., Rivera, A., Amador, W. F. O., Queiroz, I., Akabane, M. A. C. C., Consoli, L. N., Sobral, M. V. S., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101303 · Cited by 10
Szatrowski, A., Maggio, Z., & Khomtchouk, B. (2025) · JACC: Advances · doi:10.1016/j.jacadv.2025.101741 · Cited by 4
Metadata
- Authors
- Rohatgi, A., Westerterp, M., von Eckardstein, A., Remaley, A., & Rye, K.-A.
- Venue
- Circulation
- Published
- 2021-06-08
- Volume
- 143
- Issue
- 23
- Pages
- 2293-2309
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3168827864
- Cited by
- 333
- References
- 117
- FWCI
- 41.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.